DNAprint Genomics (DNAG)

[roachclip]

(stocky) Then I hope you're willing to accept six solid years of dismal failure. Every single product that DNAG has worked on, to include those already on the market, have been utter failures. Of course, now we have a few new lifelines like the Super EPO and Biofrontera. Problem is, there isn't any reasonable evidence that DNAG will benefit from the Biofrontera IPO. None whatsoever. As frog keeps trying to explain to everyone, if they IPO, DNAG will certainly lose a good percentage of their ownership. Mathematically it has to happen. And even if baby Jesus sent down a $500 million gift disguised as the CEO of Biofrontera, it would do nothing to help DNAG's absolutely inefficient and dishonest business model. They might have an extra $500 million, but that money would be in the hands of a group of people who do nothing but fail and then reward themselves for each failure.

Any Super EPO is years away, certainly being worked in the face of healthy competition.

When that eventually fails, I'm sure DNAG will come up with something new like a Super-Duper EPO.

And you guys will keep swallowing.

It's laughable.